Africa Regulatory Taskforce (ART)

Last Updated 26 July 2021.

3 Vaccines Approved for Use by ART

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 56 countries

  11 trials in 17 countries

  Approval Source: africacdc.org

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 119 countries

  33 trials in 19 countries

  Approval Source: africacdc.org

  Non Replicating Viral Vector

• Serum Institute of India
  Covishield (Oxford/AstraZeneca formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 45 countries

  2 trials in 1 country

  Approval Source: africacdc.org

  Non Replicating Viral Vector